Illumina, Inc. - Common Stock — 현금 흐름 (NASDAQ:ILMN)

Financials

영업활동으로 인한 현금 1.08 B545 M392 M478 M837 M1.08 B 1.13 B 투자 활동으로 인한 현금 -554 M-1.07 B-591 M-231 M-178 M-55 M -358 M 재무활동으로 인한 현금 -766 M-51 M1 B-1.21 B-570 M-744 M -800 M 잉여 현금 흐름 1.08 B545 M392 M478 M837 M931 M 974 M

Illumina, Inc. - Common Stock

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

ILMN

Financials

Illumina, Inc. - Common Stock

뉴스

Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?

Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings

QIAGEN Business Breakdown and Growth Drivers for 2026

Here's Why Illumina (ILMN) is a Strong Momentum Stock

Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy?

Is This the Right Time to Retain ILMN Stock in Your Portfolio?

What CEOs from Tesla, Nvidia and over a dozen other companies hope to gain by joining Trump in China

Elon Musk To Join Trump On China State Visit. Tesla Stock Sinks.

Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term

PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?

Here's Why Illumina (ILMN) is a Strong Growth Stock

Uber, Illumina And Diamondback Energy: CNBC’s ‘Final Trades’ - Diamondback Energy (NASDAQ:FANG), Hertz Gl